Carbetapentane citrate 0.4 % / guaiFENesin 2 % / phenylephrine hydrochloride 0.2 % Oral Solution
RxNorm 1101947
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1101947 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane citrate 0.4 % / guaiFENesin 2 % / phenylephrine hydrochloride 0.2 % Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbetapentane citrate 4 mg/ML / guaifenesin 20 mg/ML / phenylephrine hydrochloride 2 mg/ML Oral Solution
(Atom ID: 12329249)
PSN
Prescribable Name (PSN):
Carbetapentane citrate 0.4 % / guaiFENesin 2 % / phenylephrine hydrochloride 0.2 % Oral Solution
(Atom ID: 10271690)
SY
Synonym (SY):
Carbetapentane citrate 20 mg / guaifenesin 100 mg / phenylephrine hydrochloride 10 mg per 5 mL Oral Solution
(Atom ID: 3643651)
TMSY
Tall Man Lettering Synonym (TMSY):
Carbetapentane citrate 20 mg / guaiFENesin 100 mg / phenylephrine hydrochloride 10 mg per 5 mL Oral Solution
(Atom ID: 3725523)
TMSY